3398 studies found for:    Japan
Show Display Options
Rank Status Study
1 Active, not recruiting Phase 3 Study With Carfilzomib and Dexamethasone Versus Velcade and Dexamethasone for Relapsed Multiple Myeloma Patients
Condition: Multiple Myeloma
Interventions: Drug: Carfilzomib plus dexamethasone;   Drug: Velcade plus dexamethasone
2 Recruiting Investigation of the Safety and Efficacy of Iguratimod in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Drug: Iguratimod
3 Active, not recruiting Faslodex Specific Clinical Experience Investigation
Condition: Breast Cancer
4 Enrolling by invitation Success of Tocilizumab in Rheumatoid Arthritis (RA) Patients With Remission Induction and Sustained Efficacy After Discontinuation
Condition: Rheumatoid Arthritis
Interventions: Drug: Tocilizumab plus methotrexate;   Drug: Tocilizumab
5 Recruiting Forxiga Tablets Specific Clinical Experience Investigation for Long-term Use
Condition: Type 2 Diabetes Mellitus
6 Completed Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3)
Condition: Hepatitis C, Chronic
Interventions: Drug: BI 201335;   Drug: placebo/PegIFN/RBV
7 Completed A Double-Blind Study of E5555 in Japanese Patients With Acute Coronary Syndrome
Condition: Acute Coronary Syndrome
Interventions: Drug: E5555;   Drug: Placebo
8 Completed
Has Results
Filtered Trial for Amlodipine Non-responder
Condition: Hypertension
Interventions: Drug: telmisartan+amlodipine;   Drug: amlodipine
9 Completed
Has Results
An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures
Conditions: Epilepsy;   Partial Seizures
Intervention: Drug: Levetiracetam
10 Completed
Has Results
Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism
Conditions: Secondary Hyperparathyroidism;   Hemodialysis
Interventions: Drug: paricalcitol;   Drug: maxacalcitol;   Drug: paricalcitol placebo;   Drug: maxacalcitol  placebo
11 Unknown  Surgery in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor
Conditions: Gastrointestinal Stromal Tumor;   Metastatic Cancer
Intervention: Procedure: therapeutic conventional surgery
12 Active, not recruiting Nexium Capsules LDA Specific Clinical Experience Investigation
Conditions: Gastric Ulcer;   Duodenal Ulcer
13 Completed
Has Results
Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Japanese Patients With COPD
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: BI 1744 CL 2 Âµg;   Drug: BI 1744 CL 5 Âµg;   Drug: BI 1744 CL 10 Âµg;   Drug: Placebo
14 Active, not recruiting
Has Results
An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy
Conditions: Epilepsy;   Partial Onset Seizures
Intervention: Drug: Levetiracetam (LEV)
15 Completed
Has Results
Phase 2 Study of Tapentadol Prolonged Release in Cancer Pain Participants
Conditions: Pain;   Cancer
Intervention: Drug: Tapentadol PR
16 Completed A Study of SA-001 to Treat Pancreatic Exocrine Insufficiency
Condition: Exocrine Pancreatic Insufficiency, Chronic Pancreatitis
Interventions: Drug: SA-001;   Drug: Placebo
17 Completed Comparison of a New Formulation of Insulin Glargine With Lantus® Both in Combination With Oral Antihyperglycemic Drug(s) in Japanese Patients With Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Insulin glargine new formulation (HOE901);   Drug: Insulin glargine (HOE901)
18 Completed An Open Label Study for Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Drug: LY2127399
19 Active, not recruiting A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2)
Conditions: Crohn's Disease;   Inflammatory Bowel Disease;   IBD;   Colitis
Interventions: Drug: Group 3: ustekinumab approximately 6 mg/kg;   Drug: Group 1: Placebo;   Drug: Group 2 ustekinumab 130 mg
20 Completed Effect of Teriparatide on Hip Fracture Healing
Condition: Femur Neck Fracture
Interventions: Drug: Teriparatide;   Drug: Placebo;   Dietary Supplement: Calcium supplementation;   Dietary Supplement: Vitamin D supplementation

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years